Epstein Secrets

developing a team of investment analysts. Prior to joining Siegler Collery, Mr. Bommer worked from September 1993 to March 1995 as an Associate at McKinsey & Company, where he was involved in the restructuring of the sales and marketing department for a media client and the analysis of a strategic acquisition an

the Partnership and its Limited Partners which should be considered by a prospective Limited Partner. The Partnership has not sought a ruling from the Internal Revenue Service (the "Service") or any other Federal, state or local agency with respect to any of the tax issues affecting the Partnership, nor has it obtained an

L 2 DRAFT - Jeffery Epstein EFTA00617641 DNA sequencing, estimates a $20 billion addressable market for sequencing technology and applications. McKinsey & Company estimates that genomics will have an economic impact of up to $1.6 trillion on global GDP by 2025. • Smart sensors and remote-monitoring technolog

at, although the Partnership intends to adopt positions it believes are in accord with current interpretations of the U.S. federal income tax laws, the Internal Revenue Service ("IRS") may not agree with the tax STRICTLY CONFIDENTIAL 54 DRAFT - Jeffery Epstein EFTA00617693 positions taken by the Partnership and that, i

pany oversight efforts on the firm’s healthcare information technology portfolio. Prior to joining Francisco Partners, Eric worked for three years at McKinsey & Company as a Senior Business Analyst in their Corporate Finance Practice. Eric received his dual B.A. in Mathematical Methods in the Social Sciences and Econ

CONFIDENTIAL HOUSE_OVERSIGHT_024083 X. CERTAIN TAX AND ERISA CONSIDERATIONS IN ACCORDANCE WITH U.S. TREASURY REGULATIONS GOVERNING PRACTICE BEFORE THE INTERNAL REVENUE SERVICE (CIRCULAR 230), LEGAL COUNSEL TO THE FUND HEREBY INFORMS INVESTORS THAT (A) THE INFORMATION BELOW (OR OTHERWISE CONTAINED IN THIS DOCUMENT) IS NOT IN